Lataa...
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors immediately reduce the glomerular filtration rate (GFR) in patients with type 2 diabetes mellitus. When given chronically, they confer benefit by markedly slowing the rate at which chronic kidney disease progresses and are the first agents to do so...
Tallennettuna:
| Julkaisussa: | Am J Cardiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7258222/ https://ncbi.nlm.nih.gov/pubmed/31741437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2019.10.027 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|